Compugen Ltd

CGEN Nasdaq SEC CIK 1119774
Follow Compugen Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 USD · US GAAP
EPS, diluted -

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$50M$0$50M$100MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$72.8M$35.3M
FY24$27.9M−$14.2M
FY23$33.5M−$18.8M
FY22$7.5M−$33.7M
FY21$6M−$34.2M
FY20$2M−$29.7M
FY19-−$27.3M
FY18$17.8M−$22.6M
FY17-−$37.1M
FY16$712K−$31.5M
FY15$9.3M−$20.2M
FY14$12.4M−$11.1M
FY13$3.5M−$14.1M
FY12$242K−$13.6M
FY11-−$12M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−6000%−4000%−2000%0%2000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2587.3%43.1%48.6%
FY2471.5%−53.4%−51.1%
FY2394%−38.8%−56.1%
FY2287%−471.7%−449.3%
FY2188.7%−584.6%−570%
FY2097%−1574.8%−1484.9%
FY19---
FY1894.2%−130.5%−127%
FY17---
FY1668.7%−4576.3%−4425%
FY1582.4%−225.5%−217.3%
FY1473%−99.8%−89.7%
FY1329.3%−480.2%−396.8%
FY1216.9%−5595.9%−5631.4%
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$50M−$25M$0$25M$50MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$31.3M
FY24$49.5M
FY23−$36.1M
FY22−$34.6M
FY21−$23M
FY20−$28.5M
FY19−$28M
FY18−$13.4M
FY17−$31M
FY16−$22.4M
FY15−$28.7M
FY14−$13M
FY13−$6.8M
FY12−$11.9M
FY11−$9.3M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Compugen
  • Healthcare median
−6000%−4000%−2000%0%2000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearCompugenHealthcare median
FY2548.6%−30.6%
FY24−51.1%−47%
FY23−56.1%−58%
FY22−449.3%−80.4%
FY21−570%−71.9%
FY20−1484.9%−62.2%
FY19-−46.3%
FY18−127%−49.6%
FY17-−45.9%
FY16−4425%−36%
FY15−217.3%−38.4%
FY14−89.7%−35.5%
FY13−396.8%−37.1%
FY12−5631.4%−29.1%
FY11-−27.9%